Western blot assay for HSP70 (68 kDa), IgG antibody may be utilized in predicting corticosteroid responsiveness in patients with idiopathic rapidly progressive sensorineural hearing loss. Indeterminate results should be repeated using a fresh specimen collected after 10-14 days. Other autoimmune diseases may also produce positive results.
Compliance Statement B
: This test was developed and its performance characteristics determined by ARUP Laboratories. The U.S. Food and Drug Administration has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions.